|
[1]Lindor KD, Gershwin ME, Poupon R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308.
|
|
[2]European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of cholestatic liver diseases.[J].J Hepatol, 2009, 51 (2) :237-267.
|
|
[3]Parés A, Caballeíra L, Rodés J, et al.Excellent long-term sur-vival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid[J].Gastroenterology, 2006, 130 (3) :715-720.
|
|
[4]Corpechot C, Chazouillères O, Poupon R, et al.Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis[J].Hepatology, 2008, 48 (3) :871-887.
|
|
[5]Kuiper EM, Hansen BE, de Vrios RA, et al.Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxychohc acid[J].Gastroenterology, 2009, 136 (4) :128l-1287.
|
|
[6]Babatin MA, Sanai FM, Swain MG.Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy[J].Aliment Pharmacol Ther, 2006, 24 (5) :813-820.
|
|
[7]Bonis PA, Kaplan M.Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol[J].Gastroenterology.1999, 117 (2) :395-399.
|
|
[8]Kaplan MM, Bonder A, Ruthazer R, et al.Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid[J].Dig Dis Sci, 2010, 55 (11) :3207-3217.
|
|
[9]Rautiainen H, Krkkinen P, Karvonen AL, et al.Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis:a three-year randomized trial[J].Hepatology, 2005, 41 (4) :747-752.
|
|
[10]Rabahi N, Chrétien Y, Gaouar F, et al.Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone[J].Gastroenterol Clin Biol, 2010, 34 (4) :283-287.
|
|
[11]Talwalkar JA, Angulo P, Keach JC, et al.Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid[J].J Clin Gastroenterol, 2005, 39 (2) :168-171.
|
|
[12]Levy C, Peter JA, Nelson DR, et al.Pilot study:fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid[J].Aliment Pharmacol Ther, 2011, 33 (2) :235-242.
|
|
[13]Walker LJ, Newton J, Jones DE, et al.Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis[J].Hepatology, 2009, 49 (1) :337-338.
|
|
[14]Liberopoulos EN, Florentin M, Elisaf MS, et al.Fenofibrate in primary biliary cirrhosis:a pilot study[J].Open Cardiovasc Med J, 2010, 28 (4) :120-126.
|
|
[15]Iwasaki S, Ohira H, Nishiguchi S, et al.The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis:a prospective, multicenter study[J].Hepatol Res, 2008, 38 (6) :557-564.
|
|
[16]Hazzan R, Tur-Kaspa R.Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid[J].J Clin Gastroenterol, 2010, 44 (5) :371-373.
|
|
[17]Wagner M, Halilbasic E, Marschall HU, et al.CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice[J].Hepatology, 2005, 42 (2) :420-430.
|
|
[18]Awad AS, Kamel R.Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers[J].J Biochem Mol Toxicol, 2010, 24 (2) :89-94.
|
|
[19]Dold S, Laschke MW, Lavasani S, et al.Simvastatin protects against cholestasis-induced liver injury[J].J Pharmacol, 2009, 156 (3) :466-474.
|
|
[20]Stojakovic T, Putz-Bankuti C, Fauler G, et al.Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid[J].Hepatology, 2007, 46 (3) :776-784.
|
|
[21]Rambaldi A, Jacobs BP, Gluud C.Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases[J].Cochrane Database Syst Rev, 2007, 17 (4) :CD003620.
|
|
[22]Angulo P, Patel T, Jorgensen RA, et al.Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid[J].Hepatology, 2000, 32 (2) :897-900.
|
|
[23]Angulo P, Jorgensen RA, Lindor KD.Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis:is a double dosage worthwhile[J].Am J Gastroenterol, 2001, 96 (11) :152-157.
|
DownLoad: